Related Experiment Video

Updated: Jun 28, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

[Short course antibiotherapies in community-acquired pneumonia]

Yilmaz Bulbul1, Tevfik Ozlu

  • 1Department of Chest Diseases, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. bulbulyilmaz@yahoo.com

Tuberkuloz Ve Toraks
|October 22, 2008
PubMed

Insights

Short course antibiotic therapy for community-acquired pneumonia is as effective as long courses. This approach reduces antibiotic resistance, bacterial colonization, and healthcare costs.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Context:

  • Antibiotic resistance is a growing global health concern.
  • Current guidelines for pneumonia treatment duration vary.
  • Longer antibiotic courses can lead to adverse effects like resistance and increased costs.

Purpose:

  • To review the current literature on short-course antibiotic therapy for community-acquired pneumonia.
  • To evaluate the efficacy and advantages of shorter treatment durations.

Summary:

  • Recent studies indicate that short-course antimicrobial therapies for pneumonia are effective.
  • Newer fluoroquinolone and macrolide antibiotics support shorter treatment durations.
  • Short courses offer benefits including reduced bacterial colonization and lower costs compared to traditional long therapies.

Impact:

  • Short-course therapy presents a viable alternative to traditional long-course treatments for community-acquired pneumonia.
  • This approach can mitigate the development of antibiotic resistance.
  • Implementing shorter antibiotic durations may lead to significant cost savings in healthcare.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...